Percutaneous tumor ablation with radiofrequency

Bradford J. Wood, Jeffrey R. Ramkaransingh, Tito Fojo, McClellan M. Walther, Steven Libutti

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

BACKGROUND. Radiofrequency thermal ablation (RFA) is a new minimally invasive treatment for localized cancer. Minimally invasive surgical options require less resources, time, recovery, and cost, and often offer reduced morbidity and mortality, compared with more invasive methods. To be useful, image-guided, minimally invasive, local treatments will have to meet those expectations without sacrificing efficacy. METHODS. Image-guided, local cancer treatment relies on the assumption that local disease control may improve survival. Recent developments in ablative techniques are being applied to patients with inoperable, small, or solitary liver tumors, recurrent metachronous hereditary renal cell carcinoma, and neoplasms in the bone, lung, breast, and adrenal gland. RESULTS. Recent refinements in ablation technology enable large tumor volumes to be treated with image-guided needle placement, either percutaneously, lapar-scopically, or with open surgery. Local disease control potentially could result in improved survival, or enhanced operability. CONCLUSIONS. Consensus indications in oncology are ill-defined, despite widespread proliferation of the technology. A brief review is presented of the current status of image-guided tumor ablation therapy. More rigorous scientific review, long-term follow-up, and randomized prospective trials are needed to help define the role of RFA in oncology.

Original languageEnglish (US)
Pages (from-to)443-451
Number of pages9
JournalCancer
Volume94
Issue number2
DOIs
StatePublished - Jan 15 2002

Fingerprint

Neoplasms
Hot Temperature
Technology
Survival
Kidney Neoplasms
Therapeutics
Adrenal Glands
Tumor Burden
Renal Cell Carcinoma
Needles
Breast
Morbidity
Costs and Cost Analysis
Bone and Bones
Lung
Mortality
Liver

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Hyperthermia
  • Minimally invasive therapy
  • Radiofrequency thermal ablation
  • Tumor ablation

Cite this

Wood, B. J., Ramkaransingh, J. R., Fojo, T., Walther, M. M., & Libutti, S. (2002). Percutaneous tumor ablation with radiofrequency. Cancer, 94(2), 443-451. https://doi.org/10.1002/cncr.10234
Wood, Bradford J. ; Ramkaransingh, Jeffrey R. ; Fojo, Tito ; Walther, McClellan M. ; Libutti, Steven. / Percutaneous tumor ablation with radiofrequency. In: Cancer. 2002 ; Vol. 94, No. 2. pp. 443-451.
@article{62e30093b4174bbabe0c2ffadfcebf1b,
title = "Percutaneous tumor ablation with radiofrequency",
abstract = "BACKGROUND. Radiofrequency thermal ablation (RFA) is a new minimally invasive treatment for localized cancer. Minimally invasive surgical options require less resources, time, recovery, and cost, and often offer reduced morbidity and mortality, compared with more invasive methods. To be useful, image-guided, minimally invasive, local treatments will have to meet those expectations without sacrificing efficacy. METHODS. Image-guided, local cancer treatment relies on the assumption that local disease control may improve survival. Recent developments in ablative techniques are being applied to patients with inoperable, small, or solitary liver tumors, recurrent metachronous hereditary renal cell carcinoma, and neoplasms in the bone, lung, breast, and adrenal gland. RESULTS. Recent refinements in ablation technology enable large tumor volumes to be treated with image-guided needle placement, either percutaneously, lapar-scopically, or with open surgery. Local disease control potentially could result in improved survival, or enhanced operability. CONCLUSIONS. Consensus indications in oncology are ill-defined, despite widespread proliferation of the technology. A brief review is presented of the current status of image-guided tumor ablation therapy. More rigorous scientific review, long-term follow-up, and randomized prospective trials are needed to help define the role of RFA in oncology.",
keywords = "Hyperthermia, Minimally invasive therapy, Radiofrequency thermal ablation, Tumor ablation",
author = "Wood, {Bradford J.} and Ramkaransingh, {Jeffrey R.} and Tito Fojo and Walther, {McClellan M.} and Steven Libutti",
year = "2002",
month = "1",
day = "15",
doi = "10.1002/cncr.10234",
language = "English (US)",
volume = "94",
pages = "443--451",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

Wood, BJ, Ramkaransingh, JR, Fojo, T, Walther, MM & Libutti, S 2002, 'Percutaneous tumor ablation with radiofrequency', Cancer, vol. 94, no. 2, pp. 443-451. https://doi.org/10.1002/cncr.10234

Percutaneous tumor ablation with radiofrequency. / Wood, Bradford J.; Ramkaransingh, Jeffrey R.; Fojo, Tito; Walther, McClellan M.; Libutti, Steven.

In: Cancer, Vol. 94, No. 2, 15.01.2002, p. 443-451.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Percutaneous tumor ablation with radiofrequency

AU - Wood, Bradford J.

AU - Ramkaransingh, Jeffrey R.

AU - Fojo, Tito

AU - Walther, McClellan M.

AU - Libutti, Steven

PY - 2002/1/15

Y1 - 2002/1/15

N2 - BACKGROUND. Radiofrequency thermal ablation (RFA) is a new minimally invasive treatment for localized cancer. Minimally invasive surgical options require less resources, time, recovery, and cost, and often offer reduced morbidity and mortality, compared with more invasive methods. To be useful, image-guided, minimally invasive, local treatments will have to meet those expectations without sacrificing efficacy. METHODS. Image-guided, local cancer treatment relies on the assumption that local disease control may improve survival. Recent developments in ablative techniques are being applied to patients with inoperable, small, or solitary liver tumors, recurrent metachronous hereditary renal cell carcinoma, and neoplasms in the bone, lung, breast, and adrenal gland. RESULTS. Recent refinements in ablation technology enable large tumor volumes to be treated with image-guided needle placement, either percutaneously, lapar-scopically, or with open surgery. Local disease control potentially could result in improved survival, or enhanced operability. CONCLUSIONS. Consensus indications in oncology are ill-defined, despite widespread proliferation of the technology. A brief review is presented of the current status of image-guided tumor ablation therapy. More rigorous scientific review, long-term follow-up, and randomized prospective trials are needed to help define the role of RFA in oncology.

AB - BACKGROUND. Radiofrequency thermal ablation (RFA) is a new minimally invasive treatment for localized cancer. Minimally invasive surgical options require less resources, time, recovery, and cost, and often offer reduced morbidity and mortality, compared with more invasive methods. To be useful, image-guided, minimally invasive, local treatments will have to meet those expectations without sacrificing efficacy. METHODS. Image-guided, local cancer treatment relies on the assumption that local disease control may improve survival. Recent developments in ablative techniques are being applied to patients with inoperable, small, or solitary liver tumors, recurrent metachronous hereditary renal cell carcinoma, and neoplasms in the bone, lung, breast, and adrenal gland. RESULTS. Recent refinements in ablation technology enable large tumor volumes to be treated with image-guided needle placement, either percutaneously, lapar-scopically, or with open surgery. Local disease control potentially could result in improved survival, or enhanced operability. CONCLUSIONS. Consensus indications in oncology are ill-defined, despite widespread proliferation of the technology. A brief review is presented of the current status of image-guided tumor ablation therapy. More rigorous scientific review, long-term follow-up, and randomized prospective trials are needed to help define the role of RFA in oncology.

KW - Hyperthermia

KW - Minimally invasive therapy

KW - Radiofrequency thermal ablation

KW - Tumor ablation

UR - http://www.scopus.com/inward/record.url?scp=0037080266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037080266&partnerID=8YFLogxK

U2 - 10.1002/cncr.10234

DO - 10.1002/cncr.10234

M3 - Article

C2 - 11900230

AN - SCOPUS:0037080266

VL - 94

SP - 443

EP - 451

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -

Wood BJ, Ramkaransingh JR, Fojo T, Walther MM, Libutti S. Percutaneous tumor ablation with radiofrequency. Cancer. 2002 Jan 15;94(2):443-451. https://doi.org/10.1002/cncr.10234